Scotland · NHS Scotland MSAN
Ramipril 1.25mg capsules
MSAN(2026)15 · Level 2 · issued 27 Apr 2026
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 2. Ramipril 1.25mg and 2.5mg tablets and ramipril oral solution remain available but cannot | Available | — |
| angiotensin-II receptor blockers (ARBs) remain available, some of which can support increased | Available | — |
| 6. Where supplies of ramipril 1.25mg capsules are available, community pharmacists and | Available | — |
| 10. Please note, other low/lower strength formulations of ACE inhibitors and ARBs remain available | Available | — |
| but if not listed above, they cannot support increased demand. | Available — cannot support uplift | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2026:15
- Recorded
- 06 Aug 2026 21:25 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 06 Aug 2026 21:25 UTC
- Content hash
8043c59397a41c005b1350d790646faa334cee9c5e24e5007e315a627b405a9csha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2026-15.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.